Patents by Inventor Michael Wang

Michael Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240142503
    Abstract: According to various embodiments, a circuit for determining the frequency of a signal is described, comprising an input configured to receive an analog input signal, an analog to digital converter configured to convert the analog input signal to a digital input signal, a digital mixer configured to generate a mixing result signal by mixing the digital input signal with a single bit binary signal having a reference frequency, a low pass filter configured to generate a filtered signal by filtering the mixing result signal, a measuring circuit configured to measure the period of the filtered signal and an output configured to output a value differing from the frequency of the single bit binary signal by the inverse of the measured period as the frequency to be determined.
    Type: Application
    Filed: October 25, 2023
    Publication date: May 2, 2024
    Inventors: Wei Wang, Michael Augustin, Jürgen Schäfer, Dietmar König, Josef Niederl, Shane O'Neill
  • Publication number: 20240139722
    Abstract: Disclosed is a method to modify metal-organic frameworks (MOFs) by irreversible adsorption of nucleotides including, but not limited to, adenosine triphosphate (ATP), guanosine triphosphate (GTP), deoxyadenosine triphosphate (dATP), adenosine diphosphate (ADP), and adenosine monophosphate (AMP), the modified MOFs, and the use of the modified MOFs as adsorbents and catalysts.
    Type: Application
    Filed: October 27, 2023
    Publication date: May 2, 2024
    Inventors: Michael TSAPATSIS, Efrosini KOKKOLI, Danyu WANG
  • Publication number: 20240139227
    Abstract: Disclosed herein are phosphoramidate prodrugs of nucleoside derivatives for the treatment of viral infections in mammals, which is a compound, its stereoisomer, salt (acid or basic addition salt), hydrate, solvate, or crystalline form thereof, represented by the following structure: Also disclosed are methods of treatment, uses, and processes for preparing each of which utilize the compound represented by formula I.
    Type: Application
    Filed: November 16, 2023
    Publication date: May 2, 2024
    Inventors: Jinfa Du, Dhanapalan Nagarathnam, Michael Joseph Sofia, Peiyuan Wang
  • Publication number: 20240139109
    Abstract: The pharmacokinetic profile of the SGLT2 inhibitor bexagliflozin can be improved by formulating it as an extended release tablet. Compared with standard immediate-release dosage forms these tablets can permit a lower peak plasma concentration, Cmax, while maintaining plasma concentrations at therapeutic levels for a desired period. This can be used, for instance, to administer lower doses while still providing the same pharmacological effect.
    Type: Application
    Filed: November 3, 2023
    Publication date: May 2, 2024
    Inventors: Feng WANG, Ankit SHRIVASTAVA, Rina SHAH, Brian SEED, Vinay PATIL, Michael J. HADD, Fuxia DONG, Vipan DHALL, Chunfeng DAI, Joseph Ho-Lun CHAU, Qiuhua CAI
  • Patent number: 11972256
    Abstract: A system for determining code ancestry. The system includes: a memory; and a processor communicatively coupled to the memory. The processor is configured to perform a method comprising: receiving a source code file; parsing a plurality of functions out of the source code file; generating fuzzy fingerprints from the plurality of functions; and storing the fuzzy fingerprints in a graph database.
    Type: Grant
    Filed: February 16, 2022
    Date of Patent: April 30, 2024
    Assignee: International Business Machines Corporation
    Inventors: Yash Kedia, Siddharth Mehta, Matthias Seul, Michael Wang
  • Patent number: 11969500
    Abstract: The present technology relates to depots for the treatment of postoperative pain via sustained, controlled release of a therapeutic agent. In some embodiments, the depot may comprise a therapeutic region comprising an analgesic, and a control region comprising a bioresorbable polymer and a releasing agent mixed with the polymer. The releasing agent may be configured to dissolve when the depot is placed in vivo to form diffusion openings in the control region. The depot may be configured to be implanted at a treatment site in vivo and, while implanted, release the therapeutic agent at the treatment site for no less than 3 days.
    Type: Grant
    Filed: November 10, 2021
    Date of Patent: April 30, 2024
    Assignee: Foundry Therapeutics, Inc.
    Inventors: Karun D. Naga, Hanson S. Gifford, III, Stephen W. Boyd, Patrick H. Ruane, Jackie Joe Hancock, Michael Feldstein, Koon Kiat Teu, Honglei Wang, Jingnan Luo, Daniel Boon Lim Seet
  • Patent number: 11973241
    Abstract: A traction battery assembly according to an exemplary aspect of the present disclosure includes, among other things, a tray, at least one battery module, a lid secured to the tray to provide an enclosure having an interior that houses the at least one battery module, the lid having a lid aperture, and a reinforcement member is secured directly to the lid. The reinforcement member has a reinforcement member aperture. A fastener extends through the lid aperture and the reinforcement member aperture. The fastener is secured to a structure within the interior. The reinforcement member is secured directly to the lid separately from the fastener.
    Type: Grant
    Filed: October 6, 2021
    Date of Patent: April 30, 2024
    Assignee: Ford Global Technologies, LLC
    Inventors: Yongcai Wang, James Lawrence Swoish, Melissa Kathryn Christensen, Yunan Guo, Ahteram Khan, Micah Smith, Michael Luchtman
  • Patent number: 11974264
    Abstract: A Service Capability Exposure Function for a UE (U-SCEF) may be part of the UE's operating system (OS) and expose API's to applications that allow these applications to schedule data plane communications such as periodic sensor measurements or a firmware download. The U-SCEF communicates with an EPC Interworking Service that resides in the mobile network operator's (S)Gi-LAN. The EPC Interworking Service serves as an interface between the U-SCEF and the service capabilities that are exposed by the MNO via the SCEF. The U-SCEF may provide the EPC Interworking Service with information about the UE's anticipated communication schedule and mobility status. The EPC Interworking Service uses the services that are exposed by the SCEF to determine the optimal times for the UE to communicate, an optimal mobility management configuration, etc. The EPC Interworking Service negotiates a communication schedule with the EPC (SCEF) and policies on behalf of the U-SCEF.
    Type: Grant
    Filed: April 26, 2021
    Date of Patent: April 30, 2024
    Assignee: Convida Wireless, LLC
    Inventors: Michael F. Starsinic, Ahmed Mohamed, Qing Li, Rocco Di Girolamo, Chonggang Wang
  • Patent number: 11970282
    Abstract: Systems and methods of aircraft thrust management are provided. For example, a propulsion system for an aircraft comprises a fuel cell assembly comprising a fuel cell, a turbomachine, and a controller comprising memory and one or more processors. The memory stores instructions that, when executed by the one or more processors, cause the propulsion system to perform operations including receiving data indicative of a propulsion system thrust discrepancy and modifying an output of the fuel cell in response to receiving data indicative of the propulsion system thrust discrepancy. Modifying the fuel cell output may include modifying output products, an electrical power output, or both of the fuel cell to balance the thrust provided by the propulsion system.
    Type: Grant
    Filed: January 5, 2022
    Date of Patent: April 30, 2024
    Assignee: General Electric Company
    Inventors: Honggang Wang, Kum Kang Huh, Michael Anthony Benjamin, Koji Asari
  • Publication number: 20240132622
    Abstract: The present application relates to particular anti-PAD4 (peptidyl arginine deiminase 4) antibodies, nucleic acids encoding the antibodies, vectors and host cells comprising the nucleic acids, and methods of making and using the antibodies.
    Type: Application
    Filed: July 20, 2023
    Publication date: April 25, 2024
    Applicant: Bristol-Myers Squibb Company
    Inventors: Lin Hui Su, Ekaterina Deyanova, Burce Ergel Gurbuzbalaban, Mariana Nacht, Samantha Elaine Pace, Yun Wang, Qing Xiao, Ramakrishna Chandran, Shailesh Dudhgaonkar, Michael Louis Doyle, Michael Gilman, Richard Huang, Akbar Nayeem, Alok Sharma, Qihong Zhao
  • Publication number: 20240134599
    Abstract: Provided is a method for normalizing embeddings for cross-embedding alignment. The method may include applying mean centering to the at least one embedding set, applying spectral normalization to the at least one embedding set, and/or applying length normalization to the at least one embedding set. Spectral normalization may include decomposing the at least one embedding set, determining an average singular value of the at least one embedding set, determining a respective substitute singular value for each respective singular value of a diagonal matrix, and/or replacing the at least one embedding set with a product of the at least one embedding set, a right singular vector, and an inverse of the substitute diagonal matrix. The mean centering, spectral normalization, and/or length normalization may be iteratively repeated for a configurable number of iterations. A system and computer program product are also disclosed.
    Type: Application
    Filed: December 6, 2023
    Publication date: April 25, 2024
    Inventors: Yan Zheng, Michael Yeh, Junpeng Wang, Wei Zhang, Liang Wang, Hao Yang, Prince Osei Aboagye
  • Publication number: 20240132597
    Abstract: The present disclosure is generally directed to the use of compositions that include antibodies, e.g., monoclonal, chimeric, affinity-matured or humanized antibodies, antibody fragments, etc., that specifically bind one or more epitopes within a Sortilin protein, e.g., human Sortilin or mammalian Sortilin, and have improved and/or enhanced functional characteristics, in treating and/or delaying progression of a disease or injury in an individual in need thereof.
    Type: Application
    Filed: December 7, 2023
    Publication date: April 25, 2024
    Applicant: Alector LLC
    Inventors: Robert PAUL, Sam JACKSON, Omer Rizwan SIDDIQUI, Michael F. WARD, Felix Leejia YEH, Julie Y. HUANG, Whedy WANG, Yijie LIAO, Brian C. MANGAL
  • Patent number: 11964010
    Abstract: Coronavirus S ectodomain trimers stabilized in a prefusion conformation, nucleic acid molecules and vectors encoding these proteins, and methods of their use and production are disclosed. In several embodiments, the coronavirus S ectodomain trimers and/or nucleic acid molecules can be used to generate an immune response to coronavirus in a subject. In additional embodiments, the therapeutically effective amount of the coronavirus S ectodomain trimers and/or nucleic acid molecules can be administered to a subject in a method of treating or preventing coronavirus infection.
    Type: Grant
    Filed: March 8, 2021
    Date of Patent: April 23, 2024
    Assignees: The United States of America, as represented by the Secretary, Department of Health and Human Services, The Scripps Research Institute, Trustees of Dartmouth College
    Inventors: Barney Graham, Jason Mclellan, Andrew Ward, Robert Kirchdoerfer, Christopher Cottrell, Michael Gordon Joyce, Masaru Kanekiyo, Nianshuang Wang, Jesper Pallesen, Hadi Yassine, Hannah Turner, Kizzmekia Corbett
  • Patent number: 11965029
    Abstract: Described herein are compositions and methods related to antigen binding proteins that bind to human ST2, including antibodies. In particular embodiments, the disclosure provides fully human anti-ST2 antibodies and deriviatives and variants thereof. Further provided are nucleic acids encoding such antibodies and antibody fragments, variants, and derivatives. Also, provided are methods of making and using such antibodies including methods of treating and preventing autoimmune and inflammatory disorders.
    Type: Grant
    Filed: June 4, 2021
    Date of Patent: April 23, 2024
    Assignee: Amgen Inc.
    Inventors: Dirk E. Smith, Ian Foltz, Chadwick T. King, Ai Ching Lim, Rutilio Clark, Michael R. Comeau, Randal R. Ketchem, Donghui Shi, Xiaoshan Min, Zhulun Wang
  • Patent number: 11964971
    Abstract: Described herein are small molecule splicing modulator compounds that modulate splicing of mRNA, such as pre-mRNA, encoded by genes, pharmaceutical compositions comprising the same, and methods of use of the small molecule splicing modulator compounds for modulating splicing and treating diseases and conditions.
    Type: Grant
    Filed: July 29, 2021
    Date of Patent: April 23, 2024
    Assignee: SKYHAWK THERAPEUTICS, INC.
    Inventors: Michael Luzzio, Brian Lucas, Tiansheng Wang, Jun Feng
  • Patent number: 11965809
    Abstract: A method of aligning a plurality of targets is provided. The method includes generating a plurality of targets. A third phase includes the plurality of targets. The method further includes combining a first phase, a second phase, and the third phase in a volume. The first phase, the second phase, and the third phase are substantially immiscible, and the third phase is in fluid communication with the first phase and the second phase, and the first phase, the second phase, and the third phase are operable to be in a configuration of the third phase between the first phase and the second phase in the volume.
    Type: Grant
    Filed: November 12, 2021
    Date of Patent: April 23, 2024
    Inventors: Mark Andersen, Michael Pallas, Haopeng Wang
  • Patent number: 11967743
    Abstract: A propulsion system is provided including: a gas turbine engine including a combustion section having a combustor; and a modular fuel cell assembly. The modular fuel cell assembly includes: a first fuel cell string comprising a first processing unit and a first fuel cell stack, the first fuel cell stack comprising a first fuel cell defining an outlet configured to provide output products from the first fuel cell to the combustor; and a second fuel cell string comprising a second processing unit and a second fuel cell stack, the second fuel cell stack comprising a second fuel cell defining an outlet configured to provide output products from the second fuel cell to the combustor.
    Type: Grant
    Filed: February 21, 2022
    Date of Patent: April 23, 2024
    Assignee: General Electric Company
    Inventors: Honggang Wang, Radislav A. Potyrailo, Michael Anthony Benjamin
  • Patent number: 11966832
    Abstract: A method includes receiving a first data set comprising embeddings of first and second types, generating a fixed adjacency matrix from the first dataset, and applying a first stochastic binary mask to the fixed adjacency matrix to obtain a first subgraph of the fixed adjacency matrix. The method also includes processing the first subgraph through a first layer of a graph convolutional network (GCN) to obtain a first embedding matrix, and applying a second stochastic binary mask to the fixed adjacency matrix to obtain a second subgraph of the fixed adjacency matrix. The method includes processing the first embedding matrix and the second subgraph through a second layer of the GCN to obtain a second embedding matrix, and then determining a plurality of gradients of a loss function, and modifying the first stochastic binary mask and the second stochastic binary mask using at least one of the plurality of gradients.
    Type: Grant
    Filed: July 2, 2021
    Date of Patent: April 23, 2024
    Assignee: Visa International Service Association
    Inventors: Huiyuan Chen, Yu-San Lin, Lan Wang, Michael Yeh, Fei Wang, Hao Yang
  • Publication number: 20240122502
    Abstract: One or more radar sensors can be used to monitor patients in a variety of different environments and embodiments. In one embodiment, radar sensors can be used to monitor a patient's breathing, including monitoring of tidal volume, chest expansion distance, breathing rate, etc. In another embodiment, a patient position can be monitored in a patient bed, which can be used as feedback for control of bladders of a patient bed. Additional embodiments are described herein.
    Type: Application
    Filed: December 14, 2023
    Publication date: April 18, 2024
    Inventors: Stacey A. Fitzgibbons, David L. Ribble, Eric R. Meyer, Michael S. Hood, Gregory J. Shannon, Yue Wang, Charles A. Lachenbruch (Deceased), Steven D. Baker
  • Publication number: 20240129193
    Abstract: An example method includes receiving, by an SD-WAN system, WAN link characterization data for a plurality of WAN links of the SD-WAN system over a time period; and for each site of a plurality of sites of the SD-WAN system, generating, by the SD-WAN system, a local policy for the site, wherein generating the local policy is based on a machine learning model trained with the WAN link characterization data for the plurality of WAN links, and providing the local policy to an SD-WAN edge device of the site.
    Type: Application
    Filed: December 27, 2023
    Publication date: April 18, 2024
    Inventors: Jisheng Wang, Ruchit Rajkumar Mehta, Kaushik Adesh Agrawal, Patrick Timmons, Patrick J. MeLampy, Michael Baj